Your search returned 1 result.

  • CCyberKnife®
  • TTomoTherapy®
  • AAccuray
  • Pancreatic Adenocarcinoma

    The CyberKnife is well-poised to improve the local control rates−this is accomplished with high doses per fraction delivered via a highly conformal approach; improvements in systemic therapy are also necessary, which can easily be sequenced into the treatment as the CyberKnife treatment is of short duration.


This section provides CyberKnife and TomoTherapy case studies, created by Accuray in collaboration with our centers, showcasing positive outcomes. Individual treatment results may vary. Please consult a physician to discuss individual cases, including eligibility for treatment with Accuray devices.

This section also provides a selected list of publications supporting the use and efficacy of the CyberKnife and TomoTherapy Systems and is not inclusive of all available publications.

For access to a more comprehensive listing of publications related to CyberKnife and TomoTherapy Systems, visit